Drugmaker to distribute free Viramune to low-income Americans
The Boehringer Ingelheim Cares Foundation, a philanthropic branch of the drug manufacturer, has announced that it will soon begin distributing its HIV nonnucleoside reverse transcriptase inhibitor Viramune free of charge to low-income, uninsured Americans through a new assistance program. The drug will be distributed to adults and children who lack prescription drug coverage. To qualify for the program, individuals must earn less than $25,000 a year, and families of two or more people must earn less than $40,000 per year. Program participants will receive one year's worth of Viramune, distributed in four three-month supplies through the enrollee's regular health care provider. For more information about the Cares Foundation and the Viramune program, go online to us.boehringer-ingelheim.com.